1-11 of 11
Tran-Der Tan
Close
Sort by
Journal Articles

Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

Elzbieta Iskierka-Jazdzewska, Won Seog Kim, Seok-Goo Cho, Tae Min Kim, Isidro Jarque, Tadeusz Robak, Michelle Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutiérrez, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoit Tessoulin, Jingjin Li, Cristina Ivanescu, Matthew Reaney, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, James Harnett, Lei Chi, Jan Walewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4504.
https://doi.org/10.1182/blood-2023-180743
Published: 2023
Journal Articles

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Sabarish Ayyappan, Won Seog Kim, Tae Min Kim, Jan Walewski, Seok-Goo Cho, Isidro Jarque, Elzbieta Iskierka-Jazdzewska, Michelle Poon, Sung Yong Oh, Francesca Lorraine Wei Inng Lim, Cecilia Carpio, Tran-Der Tan, Antonio Gutiérrez, Huilai Zhang, Junning Cao, Mingzhi Zhang, Benoit Tessoulin, Jingjin Li, Melanie Ufkin, Saleem Shariff, Lei Chi, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, H. Miles Prince
Journal: Blood
Blood (2023) 142 (Supplement 1): 436.
https://doi.org/10.1182/blood-2023-179818
Published: 2023
Journal Articles

Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Won-Seog Kim, Tae Min Kim, Seok-Goo Cho, Isidro Jarque, Elżbieta Iskierka-Jażdżewska, Michelle Limei Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutierrez, Jingjin Li, Melanie Ufkin, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Jan Walewski
Journal: Blood
Blood (2022) 140 (Supplement 1): 1070–1071.
https://doi.org/10.1182/blood-2022-158406
Published: 2022
Journal Articles

Venetoclax and Posaconazole Plus Standard Dose Cytarabine or Azacytidine for Newly Diagnosed Acute Myeloid Leukemia

Tran-Der Tan, MD, Lun-Wei Chiou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41.
https://doi.org/10.1182/blood-2020-142409
Published: 2020
Journal Articles

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Chieh-Lin Jerry Teng, Tran-Der Tan, MD, Yu-Wen Lin, Pei-Wen Lien, Hsin-Chun Chou, Fang-Ju Lin
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
https://doi.org/10.1182/blood-2020-141186
Published: 2020
Journal Articles

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Su-Peng Yeh, MD, Ming Yao, MD, Jih-Luh Tang, MD,PhD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD, Tran-Der Tan, Po-Nan Wang, MD, Yeu-Chin Chen, MD, Wen-Li Hwang, MD, Ciyuan-jheng Wang, MD, Tsai-Yun Chen, MD, TA-Chih LIU, MD PhD, Ming-Sun Yu, MD, Tso-Fu Wang
Journal: Blood
Blood (2017) 130 (Supplement 1): 3229.
https://doi.org/10.1182/blood.V130.Suppl_1.3229.3229
Published: 2017
Journal Articles

Failure Pattern of Treatment of Hodgkin Lymphoma -- Retrospective from a Single Institution

Tran-Der Tan, MD, Lun-Wei Chiou, MD
Journal: Blood
Blood (2016) 128 (22): 5366.
https://doi.org/10.1182/blood.V128.22.5366.5366
Published: 2016
Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD
Journal: Blood
Blood (2015) 126 (23): 1593.
https://doi.org/10.1182/blood.V126.23.1593.1593
Published: 2015
Journal Articles

Outcome of Second Allotransplantation for Relapsed Hematologic Malignancies After Stem Cell Transplantation

Tran-Der Tan, Mau-Ching Wu, MD, PhD, Lun-Wei Chiou, MD
Journal: Blood
Blood (2012) 120 (21): 4461.
https://doi.org/10.1182/blood.V120.21.4461.4461
Published: 2012
Journal Articles

CD56-Positive Acute Myeloid Leukemia Has Inferior Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Tran-Der Tan, MD, Mau-Ching Wu, MD, PhD, Lun-Wei Chiou, MD
Journal: Blood
Blood (2011) 118 (21): 4493.
https://doi.org/10.1182/blood.V118.21.4493.4493
Published: 2011
Journal Articles

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Tzeon-Jye Chiou, MD, Shang-Yi Huang, MD, PhD, Cheng-Shyong Chang, MD, Sheng-Fung Lin, MD, Sung-Nan Pei, MD, Chang-Fang Chiu, MD, DMS, Ching-Liang Ho, Ming-Chih Chang, MD, Tran-Der Tan, MD, Liang-Tsai Hsiao, MD
Journal: Blood
Blood (2009) 114 (22): 4955.
https://doi.org/10.1182/blood.V114.22.4955.4955
Published: 2009